116 related articles for article (PubMed ID: 38582032)
41. Risk of long-term pelvic recurrences after fluid minihysteroscopy in women with endometrial carcinoma: a controlled randomized study.
Cicinelli E; Tinelli R; Colafiglio G; Fortunato F; Fusco A; Mastrolia S; Fucci AR; Lepera A
Menopause; 2010; 17(3):511-5. PubMed ID: 20081548
[TBL] [Abstract][Full Text] [Related]
42. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.
dos Reis R; Burzawa JK; Tsunoda AT; Hosaka M; Frumovitz M; Westin SN; Munsell MF; Ramirez PT
Int J Gynecol Cancer; 2015 Sep; 25(7):1292-9. PubMed ID: 26067863
[TBL] [Abstract][Full Text] [Related]
43. Recurrence risk factors in stage IA grade 1 endometrial cancer.
Nwachukwu C; Baskovic M; Von Eyben R; Fujimoto D; Giaretta S; English D; Kidd E
J Gynecol Oncol; 2021 Mar; 32(2):e22. PubMed ID: 33470064
[TBL] [Abstract][Full Text] [Related]
44. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.
Ben Arie A; Lavie O; Gdalevich M; Voldarsky M; Barak F; Schneider D; Levy T; Anteby E; Gemer O
Eur J Surg Oncol; 2012 Feb; 38(2):166-9. PubMed ID: 22056646
[TBL] [Abstract][Full Text] [Related]
45. The use of imaging in endometrial cancer prior to potential surgery: Are guidelines being followed?
Schnarr KL; Seow H; Elit LM; Pond GR; Helpman L; O'Leary E; Kong I
Gynecol Oncol; 2021 May; 161(2):361-366. PubMed ID: 33750604
[TBL] [Abstract][Full Text] [Related]
46. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.
Xu MJ; Chu C; Rubin S; Lin LL
Am J Clin Oncol; 2017 Dec; 40(6):598-604. PubMed ID: 26237194
[TBL] [Abstract][Full Text] [Related]
47. Three-Year Recurrence-Free Survival in Patients With a Very Low Risk of Endometrial Cancer Who Did Not Undergo Lymph Node Dissection (Tree Retro): A Korean Multicenter Study.
Kim M; Choi C; Kim K; Lim MC; Park JY; Hong JH; Lee M; Paek J; Seoung J; Lee S; Lee TS
Int J Gynecol Cancer; 2018 Jul; 28(6):1123-1129. PubMed ID: 29664841
[TBL] [Abstract][Full Text] [Related]
48. Stratification of Postsurgical Computed Tomography Surveillance Based on the Extragastric Recurrence of Early Gastric Cancer.
Seo N; Han K; Hyung WJ; Chung YE; Park CH; Kim JH; Lee SK; Kim MJ; Noh SH; Lim JS
Ann Surg; 2020 Aug; 272(2):319-325. PubMed ID: 32675545
[TBL] [Abstract][Full Text] [Related]
49. Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study.
Ørtoft G; Høgdall C; Hansen ES; Dueholm M
J Gynecol Oncol; 2020 Mar; 31(2):e22. PubMed ID: 31912677
[TBL] [Abstract][Full Text] [Related]
50. Change in hazard rates of recurrence over time following diagnosis of endometrial cancer: An age stratified multicentre study from the FRANCOGYN group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Bricou A; Huchon C; Daraï E; Ballester M;
Eur J Surg Oncol; 2018 Dec; 44(12):1914-1920. PubMed ID: 30217355
[TBL] [Abstract][Full Text] [Related]
51. Surveillance procedures for patients treated for endometrial cancer: a review of the literature.
Sartori E; Pasinetti B; Chiudinelli F; Gadducci A; Landoni F; Maggino T; Piovano E; Zola P
Int J Gynecol Cancer; 2010 Aug; 20(6):985-92. PubMed ID: 20683406
[TBL] [Abstract][Full Text] [Related]
52. Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted staging.
Menderes G; Azodi M; Clark L; Xu X; Lu L; Ratner E; Schwartz PE; Rutherford TJ; Santin AD; Silasi DA
Int J Gynecol Cancer; 2014 Jul; 24(6):1118-25. PubMed ID: 24927247
[TBL] [Abstract][Full Text] [Related]
53. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.
Kamran SC; Manuel MM; Catalano P; Cho L; Damato AL; Lee LJ; Schmidt EJ; Viswanathan AN
Brachytherapy; 2017; 16(6):1159-1168. PubMed ID: 28823395
[TBL] [Abstract][Full Text] [Related]
54. High-grade endometrial cancer: revisiting the impact of tumor size and location on outcomes.
Doll KM; Tseng J; Denslow SA; Fader AN; Gehrig PA
Gynecol Oncol; 2014 Jan; 132(1):44-9. PubMed ID: 24183734
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological Features of Early and Late Recurrence of Endometrial Carcinoma After Surgical Resection.
Takahashi A; Matsuura M; Matoda M; Nomura H; Okamoto S; Kanao H; Kondo E; Omatsu K; Kato K; Utsugi K; Takeshima N
Int J Gynecol Cancer; 2017 Jun; 27(5):967-972. PubMed ID: 28486241
[TBL] [Abstract][Full Text] [Related]
56. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
Snyder RA; Hu CY; Cuddy A; Francescatti AB; Schumacher JR; Van Loon K; You YN; Kozower BD; Greenberg CC; Schrag D; Venook A; McKellar D; Winchester DP; Chang GJ;
JAMA; 2018 May; 319(20):2104-2115. PubMed ID: 29800181
[TBL] [Abstract][Full Text] [Related]
57. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
[TBL] [Abstract][Full Text] [Related]
58. Impact of postoperative nausea and vomiting prophylaxis with dexamethasone on the risk of recurrence of endometrial cancer.
Merk BA; Havrilesky LJ; Ehrisman JA; Broadwater G; Habib AS
Curr Med Res Opin; 2016; 32(3):453-8. PubMed ID: 26583436
[TBL] [Abstract][Full Text] [Related]
59. Impact and cost of preoperative computed tomography imaging on the management of patients diagnosed with high-grade endometrial cancer.
Dai S; Nahas S; Murphy JK; Lawrence J; May T; Feigenberg T
Int J Gynaecol Obstet; 2019 May; 145(2):219-224. PubMed ID: 30784043
[TBL] [Abstract][Full Text] [Related]
60. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
